KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to -$420000.0.

  • Opko Health's Change in Accured Expenses fell 10101.17% to -$420000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.3 million, marking a year-over-year decrease of 23728.64%. This contributed to the annual value of $48.7 million for FY2024, which is 98886.25% up from last year.
  • Latest data reveals that Opko Health reported Change in Accured Expenses of -$420000.0 as of Q3 2025, which was down 10101.17% from -$24.2 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Change in Accured Expenses ranged from a high of $41.5 million in Q3 2024 and a low of -$36.2 million during Q1 2022
  • For the 5-year period, Opko Health's Change in Accured Expenses averaged around -$6.6 million, with its median value being -$8.5 million (2022).
  • Per our database at Business Quant, Opko Health's Change in Accured Expenses surged by 72629.38% in 2024 and then plummeted by 175262.66% in 2025.
  • Over the past 5 years, Opko Health's Change in Accured Expenses (Quarter) stood at $32.0 million in 2021, then crashed by 126.53% to -$8.5 million in 2022, then tumbled by 83.68% to -$15.6 million in 2023, then soared by 123.96% to $3.7 million in 2024, then tumbled by 111.26% to -$420000.0 in 2025.
  • Its Change in Accured Expenses stands at -$420000.0 for Q3 2025, versus -$24.2 million for Q2 2025 and -$19.4 million for Q1 2025.